Table 4

Studies reports on end-of-life ICU admissions

Study	Patients, N	Type of cancer	Inclusion criteria	% admitted to ICU
Mrad et al61	412 496	NSCLC	1998	13.3
Mrad et al61	412 496	NSCLC	2014	27.9
Presley et al26	43 654	NSCLC	Veterans	0.90
Presley et al26	43 654	NSCLC	Medicare beneficiaries	NR
Ersek et al42	847	NSCLC	Any	25.40
Falchook et al32	12 765	Lung	Patient <65 years	20.60
Wu et al23	49 920	All	Palliative chemotherapy <6 months	31.5
Wu et al23	49 920	All	Any chemotherapy	6.5
Wright et al14	1146	All	Any	13.20
Wang et al52	82 242	All	2005	15.30
Wang et al52	82 242	All	2009	19.50
Bekelman et al49	389 073	All	USA	5.50
			The Netherlands	7
			Belgium	11
			Canada	9.80
			UK	NR
			Germany	3.50
			Norway	NR
Choi et al30	263	All	2002	1.8
Choi et al30	263	All	2012	19.9
Cheung et al31	107 253	All	Any	5.5
Amano et al58	266	All	Early palliative care	5.60
Amano et al58	266	All	SOC	10
Zhang et al63	118	NSCLC	Any	25
Mack et al46	1231	NSCLC and colorectal	Any	9
Ho et al37	227 161	All	1993	3.06
Ho et al37	227 161	All	2003	5.39
Gonsalves et al44	200	All	2002	6
Gonsalves et al44	200	All	2008	33
Keating et al47	5826	NSCLC and colorectal	VHA cohort	12.50
Keating et al47	5826	NSCLC and colorectal	SEER cohort	19.7
Tang et al28	242 530	All	Trend 2000–2006	11.4
Temel et al36	46	NSCLC	Integrated palliative care	2
Barbera et al34	5855	All	Any	5.50
Earle et al16	28 777	All	1993	7.10
Earle et al16	28 777	All	1996	9.40

NR, not reported; NSCLC, non-small cell lung cancer;PBS, population-based study; SOC, standard of care; VHA, Veterans Health Administration.